查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区数位 PCR 市场按应用、最终用户和国家划分 - 分析和预测（2024-2034 年）
市场调查报告书
商品编码
1676618

亚太地区数位 PCR 市场按应用、最终用户和国家划分 - 分析和预测（2024-2034 年）

Asia-Pacific Digital PCR Market: Focus on Application, End User, and Country Analysis - Analysis and Forecast, 2024-2034
出版日期: | 出版商: BIS Research | 英文 62 Pages | 商品交期: 1-5个工作天内

价格

亚太地区数位 PCR (d-PCR) 市场规模预计将从 2024 年的 1.444 亿美元成长到 2034 年的 6.955 亿美元，2024-2034 年预测期间的复合年增长率为 17.02%。

个人化医疗在遗传疾病筛检和诊断的应用日益广泛，推动了亚太地区数位 PCR 市场实现两位数成长。这种针对患者的方法采用数位 PCR (dPCR) 来准确识别和测量与各种癌症相关的罕见基因突变。该地区感染疾病疫情的不断增加也加剧了对快速、准确诊断解决方案的需求。液滴数位 PCR、奈米板技术和微流体平台是一些技术进步，它们正在提高 dPCR 的功能并显着推动亚太地区市场的成长。

主要市场统计数据
预测期 2024-2034
2024 年评估 1.444亿美元
2034 年预测 6.955亿美元
复合年增长率 17.02％

在亚太地区，数位聚合酵素链锁反应（dPCR）市场正在经历强劲的两位数成长，并迅速成为一种尖端的诊断技术。随着政府计画数量的增加、医疗保健基础设施投资的增加以及研究资金的增加，dPCR 在临床和研究中的广泛应用正在推动。感染疾病、遗传性疾病和癌症发病率的上升推动了亚太地区对精准诊断的需求，以便早期发现疾病并有效监测治疗。

先进的dPCR技术显着提高了灵敏度、特异性和通量。这些技术的例子包括液滴数位 PCR、奈米板系统和微流体平台。这些发展将能够准确量化低丰度生物标记（例如罕见基因突变），从而支持标靶治疗和个人化医疗。此外，透过顺利融入标准临床工作流程，实现了快速的周转时间和较低的营运成本，这得益于自动化和直觉软体介面的进步。

亚太地区数位 PCR 市场具有进一步成长和技术进步的良好条件，这将最终改变全部区域的分子诊断模式。这是因为领先的现有企业和新兴的新兴企业都在投资研发，以解决该地区独特的临床挑战。

本报告研究了亚太地区数位 PCR 市场，并提供了市场概述、按应用、最终用户和国家分類的趋势，以及参与市场的公司概况。

目录

执行摘要

第一章 市场

  • 市场概况
  • 趋势：当前和未来的影响评估
  • 供应链概览
  • 研发回顾
  • 正在进行的数位 PCR 临床试验
  • 市场动态概览

第二章 区域

  • 区域概况
  • 驱动因素与限制因素
  • 亚太地区

第三章 市场竞争基准化分析与公司概况

  • 竞争格局
  • 市场占有率分析
  • 公司简介
    • Genetron Holdings Limited
    • RevoSketch Inc.
    • JN Medsys
    • Sysmex Corporation

第四章调查方法

Product Code: BHP2685SS

Introduction to Asia-Pacific Digital PCR Market

The Asia-Pacific digital PCR (d-PCR) market is projected to reach $695.5 million by 2034 from $144.4 million in 2024, growing at a CAGR of 17.02% during the forecast period 2024-2034. The growing use of personalised medicine for genetic disorder screening and diagnosis has propelled the APAC digital PCR market's double-digit growth. Digital PCR (dPCR) is used in this patient-specific method to precisely identify and measure uncommon genetic mutations connected to a range of cancers. The need for quick and accurate diagnostic solutions is also being fuelled by the region's rising infectious disease prevalence. Droplet digital PCR, nanoplate technology, and microfluidic platforms are examples of technological advancements that are improving dPCR capabilities and greatly bolstering the market's growth in the Asia-Pacific area.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2034
2024 Evaluation$144.4 Million
2034 Forecast$695.5 Million
CAGR17.02%

The Asia-Pacific (APAC) region is seeing strong, double-digit growth in the digital polymerase chain reaction (dPCR) market, which is quickly becoming popular as a state-of-the-art diagnostic technique. The broad use of dPCR in clinical and research applications is being fuelled by increased government programs, increased investments in healthcare infrastructure, and improved research funding. The need for high-precision diagnostics that facilitate early disease detection and efficient treatment monitoring is increasing in APAC due to the rising incidence of infectious diseases, genetic disorders, and cancers.

Advanced dPCR technologies have greatly increased sensitivity, specificity, and throughput. Examples of these technologies include droplet digital PCR, nanoplate systems, and microfluidic platforms. These developments support targeted therapies and personalised medicine by enabling the accurate quantification of low-abundance biomarkers, such as uncommon genetic mutations. Additionally, quicker turnaround times and lower operating costs are being achieved through smooth integration into standard clinical workflows made possible by advancements in automation and intuitive software interfaces.

The APAC digital PCR market is well-positioned for further growth and technological advancement, which will ultimately change the molecular diagnostics landscape throughout the region. This is due to the fact that both established industry leaders and up-and-coming startups are investing in research and development to create solutions for the region's particular clinical challenges.

Market Segmentation:

Segmentation 1: by Application

  • Clinical and Research Application
  • Environmental Application
  • Other Application

Segmentation 2: by End User

  • Academic and Research Institutes
  • Hospitals and Clinics
  • Diagnostic Centers
  • Pharmaceutical and Biopharmaceutical Companies
  • Other End User

Segmentation 3: by Country

  • China
  • Japan
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific digital PCR market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers understand which segments account for the largest share and which are well-positioned to grow in the coming years.

Competitive Strategy: The Asia-Pacific digital PCR market has numerous established players with product portfolios. Key players in the APAC digital PCR market analyzed and profiled in the study involve established players offering products for digital PCR.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts, who have analyzed company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • RevoSketch Inc.
  • JN Medsys
  • Sysmex Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Market Overview
    • 1.1.1 Workflow of Digital PCR
    • 1.1.2 Comparison of qPCR and dPCR
  • 1.2 Trends: Current and Future Impact Assessment
    • 1.2.1 Integration with Next-Generation Sequencing (NGS)
    • 1.2.2 Increased Real-time Monitoring and Point-of-care Applications of Digital PCR
    • 1.2.3 Increasing Product Launches in d-PCR Ecosystem
  • 1.3 Supply Chain Overview
  • 1.4 Research and Development Review
    • 1.4.1 Patent Filing Trend (by Region)
    • 1.4.2 Patent Filing Trend (by Country)
    • 1.4.3 Patent Filing Trend (by Year)
  • 1.5 Ongoing Digital PCR Clinical Trials
  • 1.6 Regulatory Landscape
    • 1.6.1 Asia Pacific
      • 1.6.1.1 Japan
      • 1.6.1.2 China
  • 1.7 Market Dynamics Overview
    • 1.7.1 Market Drivers
      • 1.7.1.1 Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer
      • 1.7.1.2 Increasing Incidence of Infectious Diseases
      • 1.7.1.3 Technological Advancement in dPCR to Enhance Market Growth
    • 1.7.2 Market Restraints
      • 1.7.2.1 High Cost of Platforms Associated with Digital-PCR
      • 1.7.2.2 Shortage of Skilled Professionals and Trained Laboratory Technicians
    • 1.7.3 Market Opportunities
      • 1.7.3.1 Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
      • 1.7.3.2 Growing Adoption of dPCR in Emerging Markets

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Asia-Pacific
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 Application
    • 2.3.5 By End User
    • 2.3.6 China
    • 2.3.7 Australia
    • 2.3.8 South Korea
    • 2.3.9 Japan
    • 2.3.10 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Competitive Landscape
  • 3.2 Market Share Analysis
  • 3.3 Company Profile
    • 3.3.1 Genetron Holdings Limited
      • 3.3.1.1 Overview
      • 3.3.1.2 Top Products/Product Portfolio
      • 3.3.1.3 Top Competitors
      • 3.3.1.4 Target Customers
      • 3.3.1.5 Key Personnel
      • 3.3.1.6 Analyst View
    • 3.3.2 RevoSketch Inc.
      • 3.3.2.1 Overview
      • 3.3.2.2 Top Products/Product Portfolio
      • 3.3.2.3 Top Competitors
      • 3.3.2.4 Target Customers
      • 3.3.2.5 Key Personnel
      • 3.3.2.6 Analyst View
    • 3.3.3 JN Medsys
      • 3.3.3.1 Overview
      • 3.3.3.2 Top Products/Product Portfolio
      • 3.3.3.3 Top Competitors
      • 3.3.3.4 Target Customers
      • 3.3.3.5 Key Personnel
      • 3.3.3.6 Analyst View
    • 3.3.4 Sysmex Corporation.
      • 3.3.4.1 Overview
      • 3.3.4.2 Top Products/Product Portfolio
      • 3.3.4.3 Top Competitors
      • 3.3.4.4 Target Customers
      • 3.3.4.5 Key Personnel
      • 3.3.4.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Digital PCR Market (by Application), $Million 202, 2029 and 2034
  • Figure 2: Asia-Pacific Digital PCR Market (by End User), $Million, 2023, 2029, and 2034
  • Figure 3: Key Events to Keep Track of in the Digital PCR Market
  • Figure 4: Supply Chain and Risks within the Supply Chain
  • Figure 5: Digital PCR Market (by Region), January 2020-September 2024
  • Figure 6: Digital PCR Market (by Country), January 2020-September 2024
  • Figure 7: Digital PCR Market (by Year), January 2020-September 2024
  • Figure 8: Impact Analysis of Market Navigating Factors, 2024-2034
  • Figure 9: China Digital PCR Market, $Million, 2023-2034
  • Figure 10: Australia Digital PCR Market, $Million, 2023-2034
  • Figure 11: South Korea Digital PCR Market, $Million, 2023-2034
  • Figure 12: Japan Digital PCR Market, $Million, 2023-2034
  • Figure 13: Rest-of-Asia-Pacific Digital PCR Market, $Million, 2023-2034
  • Figure 14: Strategic Initiatives, January 2019-September 2024
  • Figure 15: Share of Strategic Initiatives, January 2019-September 2024
  • Figure 16: Data Triangulation
  • Figure 17: Top-Down and Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 18: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Comparison of qPCR and dPCR
  • Table 4: Digital PCR Market, Trend Analysis
  • Table 5: Digital PCR Market, Recent Product Launches
  • Table 6: Some of the Ongoing Digital PCR (d-PCR) Clinical Trials
  • Table 7: Regulatory Framework
  • Table 8: Funding Allocated for Precision Medicine to Different Agencies Globally
  • Table 9: Cost for Different Commercialized Digital PCR (d-PCR) Platforms
  • Table 10: Digital PCR Market (by Region), $Million, 2023-2034
  • Table 11: Asia-Pacific Digital PCR Market (by Application), $Million, 2023-2034
  • Table 12: Asia-Pacific Digital PCR Market (by End User), $Million, 2023-2034
  • Table 13: China Digital PCR Market (by Application), $Million, 2023-2034
  • Table 14: China Digital PCR Market (by End User), $Million, 2023-2034
  • Table 15: Australia Digital PCR Market (by Application), $Million, 2023-2034
  • Table 16: Australia Digital PCR Market (by End User), $Million, 2023-2034
  • Table 17: South Korea Digital PCR Market (by Application), $Million, 2023-2034
  • Table 18: South Korea Digital PCR Market (by End User), $Million, 2023-2034
  • Table 19: Japan Digital PCR Market (by Application), $Million, 2023-2034
  • Table 20: Japan Digital PCR Market (by End User), $Million, 2023-2034
  • Table 21: Rest-of-Asia-Pacific Digital PCR Market (by Application), $Million, 2023-2034
  • Table 22: Rest-of-Asia-Pacific Digital PCR Market (by End User), $Million, 2023-2034